Sequencing.com: Funding, Investors & Team (Sep 2026)
In order to administer experience-based, compensated, and lifestyle loyalty programs online, in-store, or on mobile devices, Antavo is an Enterprise Loyalty Cloud. Antavo's no-code, API-centric platform allows for complete customization of the loyalty program experience and equips marketing and loyalty teams to manage their program internally without assistance from IT. 60% of Antavo's revenue is put on its product, and it produces new products every three months. Forrester, Gartner, and Loyalty360 have acknowledged Antavo as a pure-play loyalty technology vendor. Antavo is the go-to option for loyalty consultants, agencies, and system integrators worldwide. Global clients including BMW, KFC, La Cage, Kathmandu, Luisaviaroma, and BrewDog are empowered by Antavo. What distinguishes Antavo? True omnichannel solution: Most loyalty programs concentrate exclusively on online shopping.
Sequencing.com has raised $5.0M across 1 funding round on record, the most recent a Seed of $5.0M announced in Nov 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sequencing.com Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Sequencing.com Funding Rounds
Sequencing.com Founders and Leadership Team
No contact details are on record for this team yet.
Sequencing.com Funding Compared to Other Biotechnology Startups
Sequencing.com's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sequencing.com in Biotechnology and Los Angeles
Companies Similar to Sequencing.com
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sequencing.com Funding FAQs
What does Sequencing.com do?
In order to administer experience-based, compensated, and lifestyle loyalty programs online, in-store, or on mobile devices, Antavo is an Enterprise Loyalty Cloud. Antavo's no-code, API-centric platform allows for complete customization of the loyalty program experience and equips marketing and loyalty teams to manage their program internally without assistance from IT. 60% of Antavo's revenue is put on its product, and it produces new products every three months. Forrester, Gartner, and Loyalty360 have acknowledged Antavo as a pure-play loyalty technology vendor. Antavo is the go-to option for loyalty consultants, agencies, and system integrators worldwide. Global clients including BMW, KFC, La Cage, Kathmandu, Luisaviaroma, and BrewDog are empowered by Antavo. What distinguishes Antavo? True omnichannel solution: Most loyalty programs concentrate exclusively on online shopping.
How much funding has Sequencing.com raised?
Sequencing.com has raised $5.0M across 1 round on record. The most recent is a Seed of $5.0M announced in Nov 2022.
When did Sequencing.com last raise funding?
Sequencing.com's most recent funding round on record is a Seed of $5.0M, announced in Nov 2022.
Who is the CEO of Sequencing.com?
Brandon Colby Md is listed as CEO at Sequencing.com.
Where is Sequencing.com headquartered?
Sequencing.com is based in Los Angeles, California, United States.
How many employees does Sequencing.com have?
Sequencing.com is in the 11-50 employee band.
How does Sequencing.com's funding compare to other Biotechnology startups?
Sequencing.com's latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sequencing.com Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sequencing.com is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.